• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US SMARTSET GHV GENTAMICIN 40G; BONE CEMENT : BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US SMARTSET GHV GENTAMICIN 40G; BONE CEMENT : BONE CEMENT Back to Search Results
Catalog Number 3095040
Device Problem Chemical Problem (2893)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/25/2023
Event Type  malfunction  
Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
Smartset ghv was highlighted to have a different consistency after mixture.Surgeon described the cement to be lumpy and powdery despite following the cement mixing instructions.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.According to the information received, "smartset ghv was highlighted to have a different consistency after mixture.Surgeon described the cement to be lumpy and powdery despite following the cement mixing instructions." lot: 3986438.Manufacturing date: 09 nov 23.Expiry date: 31 oct 24.Quantity: (b)(4).There were two product non-conformances on this lot, neither of which had an adverse effect on the performance of the cement.The retained samples were tested in a temperature and humidity-controlled laboratory.Dough time: 55 sec.Mix characteristics: as expected.Setting time: 10 min 10 sec.The cement mixed and behaved as expected for the product type and met the appropriate control specification (ref ms-010 smartset ghv gentamicin bone cement master specification).Setting time was tested using tm-t150.The recorded setting met the control specification of 8.5 ¿ 12.5 (8 min 30s to 12 min 30s).As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.If additional information is made available, the investigation will be updated as applicable.Device history lot: a manufacturing record evaluation was performed for the finished device 3095040, lot 3986438, and no non-conformances / manufacturing irregularities were identified.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.According to the information received, "smartset ghv was highlighted to have a different consistency after mixture.Surgeon described the cement to be lumpy and powdery despite following the cement mixing instructions." lot: 3986438, manufacturing date: 09 nov 22, expiry date: 31 oct 24, quantity: (b)(4).There were two product non-conformances on this lot, neither of which had an adverse effect on the performance of the cement.The retained samples were tested in a temperature and humidity-controlled laboratory.Dough time: 55 sec mix characteristics: as expected.Setting time: 10 min 10 sec.The cement mixed and behaved as expected for the product type and met the appropriate control specification (ref ms-010 smartset ghv gentamicin bone cement master specification).Setting time was tested using tm-t150.The recorded setting met the control specification of 8.5 ¿ 12.5 (8 min 30s to 12 min 30s).As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.If additional information is made available, the investigation will be updated as applicable.Device history lot : a manufacturing record evaluation was performed for the finished device 3095040, lot 3986438, and no non-conformances / manufacturing irregularities were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMARTSET GHV GENTAMICIN 40G
Type of Device
BONE CEMENT : BONE CEMENT
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
DEPUY CMW - 9610921
cornford rd
blackpool FY4 4 QQ
UK   FY4 4QQ
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key17875828
MDR Text Key324975571
Report Number1818910-2023-20248
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
OUS - SIMILA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 10/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number3095040
Device Lot Number3986438
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/25/2023
Initial Date FDA Received10/05/2023
Supplement Dates Manufacturer Received10/11/2023
11/01/2023
Supplement Dates FDA Received10/12/2023
11/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/09/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-